2025 annual financial data
MoonLake Immunotherapeutics 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -244,834,000 USD and net income was -227,318,000 USD.
Operating cash flow was -196,007,000 USD.
Get free MoonLake Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -244,834,000 USD
- Net income
- -227,318,000 USD
- Operating cash flow
- -196,007,000 USD